Columnist Jolie Lizana is not just happy to take a day of rest for National Relaxation Day; she contends that such rest is ...

Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...

Immune cell metabolism changes may underlie PAH inflammation, which could inform targets for new PAH treatment strategies.

After positive trial results for TX45, Tectonic Therapeutic is planning a Phase 2 study to test its effects on blood flow in ...

Pulmonary hypertension (PH) is a rare, serious disease characterized by high blood pressure and damaged pulmonary arteries. These vessels, which are responsible for carrying the blood from the right ...

Pulmonary hypertension (PH) is a chronic and progressive disease associated with high blood pressure in the blood vessels that supply the lungs, known as the pulmonary arteries. Read more about PH ...

Mutations in certain genes can cause or increase the likelihood of someone developing PAH. This is known as familial or heritable PAH.

People with portopulmonary hypertension (PoPH) show lower survival rates than other PAH types, but targeted PAH treatments ...

Pulmonary hypertension (PH) is a rare, life-threatening disease that affects the pulmonary arteries, the lungs, and the heart. Patients who suffer from the disease have narrow and obstructed pulmonary ...

Pulmonary hypertension (PH) is a rare but severe health condition characterized by high blood pressure in the pulmonary arteries. It is diagnosed when the arteries that transport blood from the heart ...